Of the various drugs in each of the three major groups of bactericidal antibiotics, the aminoglycosides regularly carry some risk of producing nephrotoxic side effects [1] . Of the approximately two dozen penicillins developed [2] , so far only one (guanylureidopenicillin, BL-P1654) has recognized nephrotoxicity [31. This drug has not been released for general use.
enced by the fact that the aminoglycosides and the cephalosporins are commonly used in combination. The consistent risk of toxicity from any drug in the former group makes a further risk from one in the latter group extremely undesirable.
Studies in this laboratory have been mainly concerned with the cephalosporins. Our interest in this group of drugs was brought about by some unusual properties of cephaloridine. This antibiotic stands in sharp contrast to various other cephalosporins [5] and to the structurally related penicillins [2] in undergoing little or no net secretion by the mammalian kidney [12] [13] [14] . Cephaloridine is, however, highly cytotoxic to the proximal renal tubule [6, [12] [13] [14] [15] , the segment of the nephron responsible for the secretion of organic anions [16] , including para-amminohippurate (PAH), as well as the various penicillin and cephalosporin antibiotics [2, 5, 17] . The cytotoxicity of cephaloridine is completely prevented by probenecid [14, 18, 19] and several other inhibitors of organic anion transport [14, 20] , including the nearly nontoxic [21] cephalosporin cephalothin [22] .
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Transport and toxicity of cephaloridine Our earliest studies were directed at (1) demonstrating the existence of an unusual transport process, reflected by a substantial degree of cortical cephaloridine uptake with little or no net secretion, (2) determining the extent of the relationship between this active transport process and the nephrotoxicity of cephaloridine, and (3) defining the cellular mechanism of cephaloridine transport in the proximal tubule.
Evidence for active transport. Studies of cephaloridine transport began with the examination of its uptake by the in situ kidney cortex. The cortexto-serum concentration ratio (C/S cephaloridine) was found to be 12.2 (sEM) 0.8 in rabbits given a mildly toxic dose of 100 mg/kg, s.c., of the drug 30 minutes before sacrifice [18] . The C/S ratio in animals receiving 25 mg/kg of the drug in similar protocols [18] or 30 mg/kg by constant infusion over 1 hour [23] were essentially the same.
These C/S cephaloridine ratios are twice as high as C/S PAH ratios [23] and are eight times C/S inulin (1.5 0.2) in the same animals [18, 23] . C/S cephaloridine is reduced to levels slightly below C/S inulin by probenecid, benzylpenicillin, and PAH [18, 20, 23] . Further, the in vitro cortical slice-tomedium ratio of cephaloridine is significantly reduced by anoxia [23] . Thus, despite the absence of substantial net secretion of cephaloridine into the urine, there is strong evidence for its active transport in the proximal tubule by an organic anion se-Relationship to toxicity. C/S cephaloridine was measured in various mammalian species with and without the prior administration of probenecid.
Cortical uptake was found in the rabbit, the guinea pig, and the rat in proportion to the toxicity of the antibiotic to those species [10] . In further studies of rabbits and guinea pigs treated with fully toxic doses of the antibiotic, quantities of probenecid or PAH that failed to maintain the concentration of cephaloridine in renal cortex below 2000 gIg of wet tissue weight did not substantially reduce proximal tubular necrosis, whereas those that maintained the concentration below 1000 ig/g were associated with almost no cell necrosis (Table 1) [19, 20] . This concentration range fits with the 1839 148 jiglg resulting from a 50% nephrotoxic dose of cephaloridine in the rabbit [18] . Mechanism of transport. Two possible mechanisms were considered that could account for this occurrence of carrier-mediated uptake without significant net secretion: (1) active secretion into the proximal tubular fluid with an equal rate of reabsorption, and (2) active transport into the proximal tubular cell at the antiluminal side with limited subsequent movement into the tubular fluid.
Several lines of evidence have been developed [18, 23, 25] against the former and in support of the latter of these two proposed mechanisms. This information has been recently reviewed in some detail [11] and will not be repeated in the present discussion. The cortical content of cephaloridine therefore appears to represent, in large part, a relatively trapped cellular pool ( Fig. 1) , which is larger than that of PAH [23, 25] , other cephalosporins [26, 27] , and a variety of other antibiotics except the aminoglycosides [26, 27] . We have found no evidence of passive binding of cephaloridine in the anoxic cortical slice [23] or in homogenates of renal cortex. Instead, the high cortical cephaloridine concentrations appear to be the result of the hypothesized limitation of movement from cell-to-luminal fluid following active transport at the antiluminal side [25] .
Other cephalosporins Cefazolin, one of the newer cephalosporins, is also slightly nephrotoxic to the rabbit, but only in doses ten times greater than those of cephaloridine [7] . Cefazolin is secreted by the kidney [5] . Renal cortical cefazolin concentrations are higher, however, than those of cephalothin (the least toxic of these three cephalosporins [7, 21] ) and lower than those of cephaloridine (the most toxic of the three [7, 21] ) [27] . As in the case of cephaloridine [10, 28] , susceptibility to cefazolin toxicity increases in the newborn rabbit with maturation of the organic anion transport system [24] , and cefazolin toxicity is prevented by probenecid [10] . Because of these similarities between cephaloridine and cefazolin, we hypothesized that the various cephalosporins may share the potential for producing cytotoxicity in proportion to their intracellular concentrations [10] . The singular property of cephaloridine, which appeared to be responsible for its notable degree of toxicity, was its unusual renal transport and the resulting high local concentrations. Cephaloridine is toxic to other cell types, such as fibroblasts and HeLa cells in culture, but only at constant concentrations of 1000 tg/ml or greater [29] . It remains to be determined what other factors participate in the toxicity of the various cephalosporins. The relationship between transport and toxicity, however, is fundamental and is quantitatively impressive with cephaloridine [10, 19, 20] .
Molecular basis of toxicity
The exact mechanism of cephalosporin toxicity remains to be determined. The ultrastructural lesion produced by cephaloridine influenced our initial studies of this question.
Electron microscopic examination of the proximal tubular cell from 1 to 5 hours after the injection of cephaloridine shows a progressive focal loss of brush border, an increase in the number of apical cell vacuoles, an increase in the number and complexity of membranous structures in the apex of the cell, occasionally in the form of whorls, a loss of normal basolateral cell interdigitations, and a rounded appearance of the mitochondria [15] . Although the ultrastructural changes in mitochondria could be the result of a loss of their normal vertical orientation, there appears to be extensive alteration of membranous structures within the damaged cell.
The mitochondrion was attractive for preliminary study as an isolatable membranous organelle in which one could examine the effects of the cephalosporins on a series of processes critical to cell metabolism. Studies were therefore begun in this system. Protocols using renal cortical mitochondria and tubule suspensions were designed to study the possibility that the effects of cephalosporins on isolated mitochondria might have a role in the pathogenesis of cell injury. Renal cortical mitochondria. The effects of cephaloridine on respiration by rabbit renal cortical mitochondria were examined under two conditions:
(1) in vitro exposure: respiration studied before and after exposure of isolated mitochondria to the antibiotic; (2) in vivo exposure: respiration studied in mitochondria isolated from animals that received the antibiotic prior to sacrifice, compared with the same functions in preparations from untreated paired control animals.
Renal cortical mitochondria were isolated and studied by methods previously described in detail [30] . Respiration was studied with each of three substrate groups: (I) glutamate plus malate, (2) succinate, and (3) the artificial electron donors tetramethylphenylenediamine (TMPD) plus ascorbate, which allow a measure of cytochrome c oxidase activity [31] . The respiratory control ratio (RCR), which is the ratio of the higher rate of respiration seen in the presence of ADP (state 3) to the lower rate seen after the consumption of ADP (state 4), provides a functional measure of the intactness of these mitochondria, and presumably of their ability to generate ATP [32, 33] .
Previously published measurements of the effects of cephaloridine on cortical mitochondria are shown in Table 2 [30] . In in vitro studies, separate aliquots of normal isolated mitochondria were used for study with each of the three substrate groups, and measurements were made before and after the addition of 2000 pg/ml of cephaloridine to the res- piratory chamber. Because TMPD and ascorbate do not provide a polarographic measure of phosphorylation, the observed rate of respiration with these substrates is not an actual state 3 rate [31] . This concentration of 2000 g/ml of cephaloridine is equal to that found in renal cortex under conditions in which significant cell necrosis is seen [18, 19] . It reduces state 3 rates and RCR's with the natural substrates, as well as respiration with TMPD plus ascorbate. The effect is most striking with succinate, with which the response to ADP is immediately and completely inhibited. Further in vitro studies with one third of this concentration of cephaloridine show a significant but significantly lower reduction of the state 3 rate and the respiratory control ratio with succinate [30] .
In studies of in vivo exposure, also shown in Table 2 , 200 mg/kg of cephaloridine was injected s.c. into rabbits 2 hours before sacrifice for isolation of the mitochondria [30] . The toxicity of cephaloridine to cortical mitochondria measured by this method is qualitatively the same, although less severe, than is that seen after in vitro exposure. The most striking effect is a reduction of ADP-dependent respiration with succinate as substrate.
Reversibility of the in vitro effect. The lower degree of measured toxicity of cephaloridine to mitochondria exposed in vivo by administration of a toxic dose before sacrifice, compared with that seen after in vitro exposure of normal isolated mitochondria, raised the question of reversibility of the in vivo toxic effect during the process of isolation and washing.
In an effort to examine this possibility, we added 2000 .tg/ml of cephaloridine to one half of an initial cortical homogenate prepared for isolation of mitochondria from untreated rabbits. The other half of the homogenate, to which the saline diluent was added, was used to prepare a paired, untreated control suspension. The subsequent centrifugation, The mitochondria exposed to 2000 tg/ml of the antibiotic early in this isolation procedure show some decrease in respiratory rates compared with the controls (Table 2 ). The overall degree of inhibition, however, is not as severe or as consistent as that seen when the same concentration of cephaloridine is added to normal mitochondria in the respiratory chamber. Only the state 3 rates with glutamate and malate are significantly below control values. Thus, it appears that the isolation procedure may significantly dilute the effect of the drug on mitochondrial respiration and that the in vivo studies (mitochondria isolated from drug-treated animals) could result in an underestimate of the actual in situ effect of cephaloridine.
Renal tubule suspensions. Further evaluation of the effect of cephaloridine on respiration by the mitochondrion in the intact cell was done in studies of renal cortical tubules. Tubule suspensions were prepared by the method of Burg and Orloff [34] . Rates of respiration were measured in the same chamber and using the same units applied in studies of isolated mitochondria.
The effect of cephaloridine on tubular cell respiration was measured under three conditions ( to 2000 tg/ml of the antibiotic; (2) in vitro longerterm exposure to the same concentration (in all media throughout the entire process of preparation of the tubules, approximately 2 hours); and (3) in vivo exposure by the s.c. injection of 400 mg/kg of cephaloridine 2 hours before the animals were sacrificed. The high drug concentration was used because cellular cephaloridine uptake is not nearly as great in vitro as it is in vivo [23] . The large in vivo dose was chosen because only some components of mitochondrial respiration are reduced by 200 mg/kg of cephaloridine, and we were not examining ADPdependent respiration solely or directly in the intact cell.
These measurements in tubule cells provide preliminary supportive evidence that cephaloridine nephrotoxicity may be mediated at least partly through an effect on mitochondrial respiration. The lack of immediacy of inhibition of oxygen consumption in renal tubules after in vitro exposure is of note, and leads one to conclude that the in situ (in- tracellular) mitochondrion is in some way isolated from the antibiotic transport pool. Longer term in vitro exposure of tubules, however, provides evidence that this isolation may not be maintained as cephaloridine toxicity develops. We will return to the respiratory inhibiting effects of the cephalosporins later in this discussion.
Metabolite hypothesis
One possible reason for a delayed expression of drug-induced cytotoxicity is the requirement for transformation to a toxic metabolite. Such a requirement has been suggested for cephaloridine. McMurtry and Mitchell have reported that two inhibitors of cytochome P-450 oxidase activity, cobaltous chloride and piperonyl butoxide, reduce the liver or renal toxicity of several substituted thiophenes, including cephaloridine, in the mouse and the rat [35] . They concluded that the hepatotoxicity or nephrotoxicity of these compounds is mediated by a highly reactive metabolite-an epoxide produced by P-450 oxidase modification of the thiophene ring. Because phenobarbital, which is a stimulator of hepatic but not of renal oxidase activity, does not increase cephaloridine nephrotoxicity, the intrarenal formation of a toxic metabolite was proposed [35, 36] .
A reactive metabolite of cephaloridine was not demonstrated, and one important concern about this hypothesis was expressed. In a more thoroughly studied model of this type of metabolite-mediated toxicity, that of acetaminophen [36] , the metabolite can be rendered harmless by intracellular glutathione. Cell injury or death results only under conditions in which this sulfhydryl compound is depleted [36, 37] . Cephaloridine, unlike the other substituted thiophenes studied, produces no reduction of renal glutathione [37] .
Cephaloglycin toxicity and transport
To determine the importance of the thiophene ring, we examined the potential cytotoxicity of several cephalosporins in the guinea pig. This species was chosen for screening studies because it is relatively sensitive to cephalosporin toxicity but is small enough to permit the economic use of large drug doses. Benzylpenicillin was also studied because of a previously expressed concern that the guinea pig is unusually sensitive to the nephrotoxicity of the penicillins and cephalosporins in general [38] .
As seen in Table 4 , a comparable degree of proximal tubular cytotoxicity was seen with equal doses Table 1 of cephaloridine and cephaloglycin but not with significantly larger doses of the other cephalosporins or of benzylpenicillin. We did not study the very large doses of cefazolin that produce tubular necrosis in the rabbit [7, 10] . The finding of a comparable degree of nephrotoxicity of cephaloglycin and cephaloridine has important implications. It indicates that significant nephrotoxicity is not an unusual feature of an unusual cephalosporin. Instead, we have two highly toxic cephalosporins and two known to be mildly toxic in the rabbit (cefazolin [7, 10] and cefamandole [8] ). All four drugs cause a proximal tubular necrosis [6-8, 10, 15] . Probenecid has been studied with the first three and has been found to protect against each [10, 14, 18 ].
Cephalothin, which has a thiophene side-ring (Fig. 2) , is nearly nontoxic [21] . Cephaloridine, which has the same side-ring, is highly toxic [7, 21] . Cephalexin, which has a phenylglycyl radical group substitution, is relatively nontoxic [38] . Cephaloglycm, which has the same radical group, is highly toxic. Cephaloglycin and cephaloridine do not share the R' radical group substitution. Cefazolin and cefamandole (not shown here) share no radical group with one another or with the two more toxic cephalosporins [5] . The common denominator in the nephrotoxicity of the cephalosporins must therefore involve the core structure to a great extent and cannot be simply equated to their radical group substitutions.
We have in cephaloglycin another cephalosporin for the further testing of the hypothesis that the nephrotoxicity of this family of antibiotics may relate to the accumulation of unusually large or trapped pools of intracellular drug, and for the further investigation of the molecular basis of cephalosporin toxicity.
those of cephaloridine (P <0.001 in both cases) and are not significantly different from those of the nontoxic cephalexin. In further contrast to cephaloriCephalothin dine, the cortical concentrations of which remain substantial 3 hours after injection, cortical concentrations of cephaloglycin have diminished significantly by 2 hours (P < 0.05). In keeping with the occurrence of active secretion of cephaloglycin and cephalexin into the urine by the organic anion transport system [5] , the cortical concentrations and the disappearance of these two drugs from renal cortex are more like those of PAH than those of the relatively trapped cephaloridine [19, 20, 25] . Differences between the toxicity of cephaloridine and cephaloglycin. Electron microscopic examination of the lesion produced by cephaloglycin is currently being done by Dr. Fred Silverblatt at the U.C.L.A. -Sepulveda Veterans Administration Hospital. The results are too preliminary for detailed description, but the changes in mitochondrial configuration appear essentially the same as those produced by cephaloridine.
Even if cephaloridine and cephaloglycin are cytotoxic through a related molecular event, certain fundamental differences in their action must exist. Because the cortical concentration of cephaloglycin is lower and more transient than that of cephaloridine, cephaloglycin must act more quickly on or cause a more irreversible insult to the target receptor than does cephaloridine, or it must bind more firmly to the receptor. We have obtained the following evidence that such differences between the two cephalosporins exist:
First, as seen in Table 6 , both are equally toxic to guinea pigs when given in single doses. Cephaloglycm, however, shows a striking cumulative toxicity when given in a series of single daily nontoxic Cortical concentrations. Measurements in guinea pigs of the in situ cortical concentrations of cephaloglycin and cephalexin are presented in Table 5 , along with previously published data obtained with cephaloridine [19] . All animals received 400 mg/kg, s.c., of the respective cephalosporin 0.5 to 3.0 hours before sacrifice. Cephaloglycin and its major metabolite, desacetylcephaloglycin [40] , are measured with equal reactivity by our fluorimetric assay; the total pool will presently be referred to simply as cephaloglycin.
The cortical concentrations and C/S ratios of cephaloglycin at 0.5 hour are one half to one third of Cefazol in Table 6 . Single dose and cumulative nephrotoxicity of cephaloridine and cephaloglycin in the guinea piga Scored as in Table 1 doses, possibly because of an irreversible component of binding or damage at the molecular level. Even though cephaloridine is the more slowly excreted of the two drugs [5] , its cumulative toxicity is minimal, as has also been noted in other laboratories [21, 41] . Second, cephaloglycin toxicity to mitochondrial respiration with succinate as substrate is approximately twice that of cephaloridie in vitro (Table 7) . Cephaloglycin, 1000 tgIml, reduces the state 3 rate and the RCR by approximately as much as does 2000 g/ml of cephaloridine. Both the control and the cephaloridine-inhibited rates in these more recent studies are higher than those noted earlier [11, 30] , possibly as a result of improved technique. The respiratory toxic effects of both cephalosporins are, however, qualitatively the same as previously seen with cephaloridine [30] .
Finally, we are able to demonstrate a degree of toxicity to mitochondria after in vivo exposure to cephaloglycin that has not been possible with cephaloridine. Table 8 shows the results of studies of mitochondria from control rabbits and from animals that received 300 mg/kg of cephaloridine or 200 mgI kg of cephaloglycin (doses of equivalent toxicity in this species) 1 hour before sacrifice.
Although severe toxicity was seen in mitochondria from two of seven animals that received cephaloridine, a significant toxic effect for the entire group is seen at this early time only with the respiratory control ratio with succinate. In contrast, cephaloglycin results in a substantial reduction of both measures of respiration with both substrate groups.
The equivalent mitochondrial toxicity of cephaloglycin with in vivo and in vitro exposure is nota- b N = 7 animals. N = 6 animals.
d Microatom equivalents oxygen consumed per minute per gram of protein P < 0.001 for E/C vs. 100%; NS for cephaloridine vs cephaloglin for both measurements. bly different from the pattern previously noted with cephaloridine (Table 2) . If the partial reversibility of cephaloridine toxicity by the mitochondrial isolation process (Table 2 ) accounts for its lower measured in vivo toxicity compared with that seen in vitro, then the more easily demonstrated in vivo toxicity of cephaloglycin may be taken as further evidence for the existence of an irreversible component of the damaging effect of the latter cephalosporin. More importantly, the results of the in vivo studies with cephaloglycin provide new evidence of the importance of the toxicity of the cephalosporins to mitochondrial respiration in situ. The timing of the studies shown in Table 8 coincides with the earliest demonstrated cytotoxic changes resulting from cephaloridine [15] , at which time no structural changes in tubular cell mitochondria are noted with either cephalosporin. Preliminary studies with the nontoxic cephalexin show no significant in vivo mitochondrial inhibitory effect with succinate as substrate (unpublished). Although further studies will be needed to document a causeand-effect relationship between the respiratory and the proximal tubular toxicity of the cephalosporins, the data presented above provide new evidence in support of this hypothesis.
Clinical implications
The nephrotoxicity of cephaloridine in humans has limited its use significantly [1, 5, 9] . The toxicity of cephaloglycin is presumably a reason for its being released only for oral administration; the clinical use of this cephalosporin has been very limited [1, 5] . Massive infusions of cephalothin have been reported to cause acute tubular necrosis in humans [4] , and it is possible that this complication developed because of the establishment of high and sustained intracellular antibiotic concentrations. Cefazolin [4] and cefamandole [42, 43] have not presented obvious problems of nephrotoxicity in clinical trials. Because of this experience and their low degree of toxicity even in the rabbit [7, 8, 10] , there has been no restriction of the use of these newer cephalosporins in proper doses (modified where prerenal azotemia or renal insufficiency exist) and where specifically indicated. An area of important concern is the question of additive toxicity of cephalosporins and aminoglycosides. Evidence has been presented for [44] [45] [46] [47] and against [46, 48] such an interaction in surveys of human use. Studies in rat [27, [49] [50] [51] and the rabbit [52] have not provided evidence of additive toxicity. We must remain cautious, however, in extending conclusions reached from these animal studies of this drug interaction to the clinical setting. Large differences in sensitivity to the nephrotoxicity of antibiotics are seen between various species. For example, rats are unusually resistant to the cephalosporins [6, 7, 12] , in contrast to rabbits, guinea pigs, monkeys, and probably humans [6, 7, 9] . Rabbits are relatively resistant to amino- The animal studies done so far may therefore be inadequate for application to clinical use. No toxicity was seen in cephalosporin control groups in the several studies of combined antibiotic administration in rats [27, 49-5 1] . Some degree of toxicity was seen with the aminoglycoside and the cephalosporin in single-drug control groups in the studies done in this laboratory with rabbits [52] . We had not yet begun to work with cephaloglycin, however, and cephaloridine was the only cephalosporin tested. Aminoglycoside toxicity is cumulative [53, 54] , whereas that of cephaloridine is not. The striking difference between the cumulative cytotoxic effects of cephaloridine and cephaloglycin (Table 6 ) leads us to conclude that further study of the toxic interaction of aminoglycosides and various cephalosporins is necessary both in humans and in laboratory animals that are sensitive to both groups of drugs.
An understanding of the basic mechanisms of toxicity of these antibiotics should be pursued to permit the recognition and manipulation in appropriate animal models of circumstances that could augment or diminish their individual and potentially additive insult to the kidney in human use.
Summary. Certain members of the cephalosporin group of antibiotics have the potential for producing acute proximal tubular necrosis. This renal toxicity is a potential problem with cephaloridine in the therapeutic dose range. Although cefazolin and cefamandole have no documented significant nephrotoxicity in human use, very large doses of these cephalosporins produce the same lesion in laboratory animals as does cephaloridine. The striking toxicity of cephaloridine is closely related to unusually high cortical antibiotic concentrations. Several lines of evidence have been presented that these high concentrations are the result of a relative restriction of movement of cephaloridine into the luminal fluid after its active transport into the proximal tubular cell at the antiluminal side. Evidence is presented here that cephaloridine toxicity is at least partly mediated by an inhibitory effect on tubular cell mitochondrial respiration.
Recent studies with cephaloglycin, a cephalosponfl released only for oral administration, have shown it to be at least as toxic as cephaloridine in rabbits and guinea pigs. Cortical concentrations of cephaloglycin, however, are much lower than those of cephaloridine and are no higher than those of the nontoxic cephalexin. In further contrast, the prolonged intracellular trapping seen with cephaloridine does not occur with cephaloglycin. Preliminary evidence is discussed that lends support to the hypothesis that cephaloridine may act as a relatively reversible toxin at the intracellular level, with tubular necrosis resulting from persistent and high local concentrations, and further that the molecular toxicity of cephaloglycin is greater and/or more irreversible, resulting in necrosis after the more transient occurrence of lower intracellular concentrations.
